Insightful Plasma Therapy Market Report 2025 – For Product, Marketing, and Strategy Teams

 Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.

How has the plasma therapy market size changed in recent years, and what is the outlook ahead?
The plasma therapy market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing awareness of the benefits of plasma therapy, government support for plasma therapy, reimbursement coverage for plasma therapy, increasing demand for minimally invasive procedures, rising demand for personalized medicine, growing geriatric population.

The plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.88 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing adoption of immunoglobulins, expanding applications, rising demand for rare diseases treatment, customized therapies. Major trends in the forecast period include development of new and improved plasma therapy techniques, biological manufacturing, cell-free plasma therapies, telemedicine integration, research into new applications.

Download Your Free Sample PDF:
Global Plasma Therapy Market Analysis, Share And Growth Sample

What are the top economic and technological drivers pushing plasma therapy market growth?
The rising cases of osteoarthritis are expected to drive the plasma therapy market during the forecast period. Platelet-rich plasma (PRP), a type of plasma therapy, is considered a safe and efficient treatment for osteoarthritis. Platelet-rich plasma (PRP) is a concentrated autologous blood growth factor that is injected into the joint to provide symptomatic relief by decreasing inflammation and slowing the progression of osteoarthritis. For instance, in September 2023, according to the Journal of Elsevier, a Netherlands-based publishing company, by 2050, the projected rise in osteoarthritis cases globally is expected to be 74.9% (ranging from 59.4% to 89.9%) for the knee, 48.6% (ranging from 35.9% to 67.1%) for the hand, 78.6% (ranging from 57.7% to 105.3%) for the hip, and 95.1% (ranging from 68.1% to 135.0%) for other osteoarthritis types. Some of the most commonly used treatments for osteoarthritis are autologous chondrocyte implantation and scaffold implants. Therefore, an increase in the prevalence of osteoarthritis is expected to drive the plasma therapy market.

How is the plasma therapy market segmented by product, application, and end-user?
The plasma therapy market covered in this report is segmented –

1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes

Subsegments:
1) By Pure PRP: High Concentration PRP, Low Concentration PRP
2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors
3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF
4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes

View The Full Market Report:
Global Plasma Therapy Market Analysis, Share And Growth

What evolving trends are creating new opportunities in the plasma therapy market?
Major companies operating in the plasma therapy market are introducing innovative products such as the ESG-410 to cater to the evolving needs and enhance treatment options. The ESG-410 is an Electrosurgical Generator designed to provide options and efficiencies in the treatment of NMIBC (non-muscle-invasive bladder cancer) and benign prostatic hyperplasia. For instance, in June 2023, Olympus Corporation, a Japan-based medical technology company launched the next-generation electrosurgical generator, ESG-410. This is used for treating bladder cancer and enlarged prostate. The ESG-410 features advanced design elements, such as enhanced capacitors, ensuring superior plasma stability during ignition. It boasts rapid ignition and optimized plasma stability, offering improvements over the ESG-400, especially when used with various loop sizes and oval buttons. The ESG-410 Electrosurgical Generator offers advanced treatment options for NMIBC and BPH by providing a range of resection loops, electrodes, and vaporization tools.

Which leading companies are dominating the plasma therapy market landscape?
Major companies operating in the plasma therapy market include Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

Which geographic areas are expected to offer the highest growth opportunities in theplasma therapy market?
The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

How Can Companies Use The Plasma Therapy Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
Global Plasma Therapy Market Analysis, Share And Growth

Need Customized Data On Plasma Therapy Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
Global Plasma Therapy Market Analysis, Share And Growth Customise

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn